EDGAR Filing Documents for 0001683168-17-000550

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001683168-17-000550

Filing Date

2017-03-13

Accepted

2017-03-13 16:46:36

Documents

Period of Report

2017-01-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	peregrine_10q-013117.htm	10-Q	431456
2	CERTIFICATION OF CHIEF EXECUTIVE OFFICER	peregrine_10q-ex3101.htm	EX-31.1	8586
3	CERTIFICATION OF CHIEF FINANCIAL OFFICER	peregrine_10q-ex3102.htm	EX-31.2	9044
4	CERTIFICATION	peregrine_10q-ex3200.htm	EX-32	6527
	Complete submission text file	0001683168-17-000550.txt		3166386

Data Files

Seq	Description	Document	Type	Size
5	XBRL INSTANCE FILE	pphm-20170131.xml	EX-101.INS	666124
6	XBRL SCHEMA FILE	pphm-20170131.xsd	EX-101.SCH	31620
7	XBRL CALCULATION FILE	pphm-20170131_cal.xml	EX-101.CAL	56598
8	XBRL DEFINITION FILE	pphm-20170131_def.xml	EX-101.DEF	113567
9	XBRL LABEL FILE	pphm-20170131_lab.xml	EX-101.LAB	225578
10	XBRL PRESENTATION FILE	pphm-20170131_pre.xml	EX-101.PRE	203925

Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780

Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000

PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)